Share of Clicks for top 10 US Healthcare & Medical Medicines brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| cvs.com | 34.69 |
| walgreens.com | 7.73 |
| uqora.com | 2.67 |
| vyepti.com | 1.83 |
| goodrx.com | 1.61 |
| treatmyuti.com | 1.07 |
| lilly.com | 1.04 |
| nurtec.com | 1.01 |
| admired.com | 0.96 |
| pfizerforall.com | 0.9 |
| others | 46.49 |
- cvs.com - 34.69%
- walgreens.com - 7.73%
- uqora.com - 2.67%
- vyepti.com - 1.83%
- goodrx.com - 1.61%
- treatmyuti.com - 1.07%
- lilly.com - 1.04%
- nurtec.com - 1.01%
- admired.com - 0.96%
- pfizerforall.com - 0.9%
- others - 46.49%
Copyright © Adthena. All rights reserved.
In the competitive landscape of Google PPC ads, CVS dominates with a 34.69% click share. Walgreens follows at 7.73%, while ‘others’ collectively hold a significant 46.49%.
Share of Spend for the top 10 US Healthcare & Medical Medicines brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | cvs.com | nurtec.com | walgreens.com | uqora.com | ozempic.com | vyepti.com | goodrx.com | ro.co | lilly.com | wegovy.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025/12/01 | 16.4% | 1.88% | 3.24% | 2.42% | 3.47% | 2.1% | 2.96% | 4.12% | 2.87% | 3.33% |
| 2025/12/02 | 25.13% | 1.52% | 5.29% | 3.11% | 3.43% | 1.13% | 2.9% | 3.26% | 2.05% | 0.74% |
| 2025/12/03 | 27.12% | 1.46% | 3.85% | 3.46% | 0.86% | 1.88% | 1.81% | 3.93% | 2.11% | 2.23% |
| 2025/12/04 | 22.22% | 1.39% | 2.32% | 2.58% | 3.28% | 2.3% | 1.49% | 3.94% | 2.74% | 2.41% |
| 2025/12/05 | 26.93% | 1.61% | 2.84% | 1.59% | 1.59% | 2.54% | 1.76% | 3.34% | 2.76% | 2.65% |
| 2025/12/06 | 23.3% | 1.82% | 3.39% | 2.05% | 3.61% | 2.89% | 1.43% | 3.06% | 3.14% | 2.63% |
| 2025/12/07 | 19.23% | 1.61% | 3.42% | 2.7% | 3.57% | 3.02% | 1.94% | 3.96% | 3.55% | 1.94% |
| 2025/12/08 | 13.61% | 1.98% | 2.1% | 2.57% | 2.84% | 3.28% | 2.01% | 6.04% | 3.96% | 3.96% |
| 2025/12/09 | 13.04% | 2.07% | 2.33% | 3.17% | 2.21% | 3.05% | 2.06% | 5.89% | 3.75% | 2.65% |
| 2025/12/10 | 15.55% | 2.1% | 2.9% | 3.15% | 0.48% | 3.1% | 2.23% | 5.86% | 2.85% | 2.61% |
| 2025/12/11 | 13.92% | 1.79% | 2.5% | 2.61% | 1.78% | 3.23% | 2.04% | 4.09% | 3.32% | 2.42% |
| 2025/12/12 | 12.17% | 1.89% | 2.28% | 3.02% | 5.34% | 3.83% | 1.97% | 0.92% | 3.26% | 3.38% |
| 2025/12/13 | 13.86% | 1.54% | 3.53% | 3.86% | 2.05% | 3.36% | 2.31% | 0.43% | 2.25% | 1.42% |
| 2025/12/14 | 11.9% | 2% | 2.27% | 2.76% | 5.26% | 3.19% | 2.26% | 0.99% | 2.98% | 2.46% |
| 2025/12/15 | 12.09% | 2.49% | 2.69% | 2.07% | 2.72% | 3.68% | 1.95% | 1.53% | 3% | 4.04% |
| 2025/12/16 | 12.67% | 2.37% | 3.99% | 2.39% | 1.74% | 3.52% | 2% | 0.96% | 2.54% | 2.88% |
| 2025/12/17 | 10.78% | 2.32% | 3.27% | 3.73% | 3.32% | 3.49% | 1.82% | 0.69% | 2.97% | 3.39% |
| 2025/12/18 | 16.86% | 1.54% | 5.67% | 3.54% | 2.85% | 2.84% | 1.59% | 1.09% | 2.59% | 3.16% |
| 2025/12/19 | 17.58% | 2.91% | 4.97% | 2.7% | 2.25% | 3.33% | 1.97% | 1.09% | 2.45% | 2.25% |
| 2025/12/20 | 21.12% | 2.77% | 5.93% | 3.07% | 1.73% | 3.01% | 1.95% | 0.62% | 1.96% | 1.94% |
| 2025/12/21 | 21.41% | 2.41% | 5.45% | 2.68% | 0.27% | 2.77% | 2.05% | 0.54% | 2.43% | 2.28% |
| 2025/12/22 | 32.48% | 1.64% | 5.11% | 2.99% | 0.31% | 2.22% | 1.1% | 0.32% | 1.4% | 1.39% |
| 2025/12/23 | 27.58% | 1.27% | 5.24% | 3.16% | 1.65% | 2.18% | 1.26% | 0.7% | 2.03% | 1.31% |
| 2025/12/24 | 25.75% | 1.31% | 6.96% | 2.4% | 2.9% | 2.26% | 1.09% | 1.08% | 1.85% | 1.37% |
| 2025/12/25 | 24.36% | 1.5% | 5.02% | 2.23% | 0.48% | 2.8% | 1.64% | 0.61% | 2.14% | 2.57% |
| 2025/12/26 | 16.02% | 1.57% | 4.92% | 2.55% | 2.9% | 3.52% | 1.86% | 0.61% | 2.91% | 1.44% |
| 2025/12/27 | 18.63% | 0.83% | 5.02% | 3.12% | 2.03% | 2.82% | 2.3% | 0.8% | 2.34% | 2.41% |
| 2025/12/28 | 16.99% | 0.74% | 5.59% | 2.97% | 4.2% | 2.78% | 1.63% | 1.51% | 2.95% | 3.55% |
| 2025/12/29 | 18.82% | 0.92% | 4.61% | 2.9% | 4.21% | 2.1% | 1.54% | 1.34% | 3.28% | 1.2% |
| 2025/12/30 | 21.07% | 1.29% | 4.4% | 3.58% | 4.4% | 1.91% | 0.8% | 1.5% | 1.81% | 0.01% |
| 2025/12/31 | 23.12% | 4.12% | 3.81% | 3.81% | 2.07% | 1.92% | 0.99% | 0.97% | 0.93% | 0.01% |
- cvs.com
- nurtec.com
- walgreens.com
- uqora.com
- ozempic.com
- vyepti.com
- goodrx.com
- ro.co
- lilly.com
- wegovy.com
Copyright © Adthena. All rights reserved.
CVS dominated December’s PPC landscape, peaking mid-month. Walgreens and Uqora showed consistent growth, while Nurtec and Ozempic fluctuated. The month concluded with CVS leading, followed by Walgreens.
Competitor Count for US Healthcare & Medical Medicines
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2025/12/01 | 1910 |
| 2025/12/02 | 1919 |
| 2025/12/03 | 2058 |
| 2025/12/04 | 2058 |
| 2025/12/05 | 2126 |
| 2025/12/06 | 2083 |
| 2025/12/07 | 2040 |
| 2025/12/08 | 1996 |
| 2025/12/09 | 2053 |
| 2025/12/10 | 2035 |
| 2025/12/11 | 2054 |
| 2025/12/12 | 2040 |
| 2025/12/13 | 1961 |
| 2025/12/14 | 1993 |
| 2025/12/15 | 1996 |
| 2025/12/16 | 2014 |
| 2025/12/17 | 1944 |
| 2025/12/18 | 2078 |
| 2025/12/19 | 2096 |
| 2025/12/20 | 2091 |
| 2025/12/21 | 2129 |
| 2025/12/22 | 2253 |
| 2025/12/23 | 2264 |
| 2025/12/24 | 2245 |
| 2025/12/25 | 2186 |
| 2025/12/26 | 2127 |
| 2025/12/27 | 2164 |
| 2025/12/28 | 2161 |
| 2025/12/29 | 2165 |
| 2025/12/30 | 2129 |
| 2025/12/31 | 2106 |
Copyright © Adthena. All rights reserved.
December saw a dynamic shift in distinct advertisers, starting at 1,910 and peaking at 2,264. The month concluded with 2,106 advertisers, reflecting a vibrant competitive landscape.
